What is Luxvitae Therapeutics worth?
$41.9Mlast known valuation
Luxvitae Therapeutics last raised $8.5M in its Early Stage VC (Nov 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Luxvitae Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2024 | Early Stage VC | $8.5M | ▮ | ▮ |
How Luxvitae Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Luxvitae Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Luxvitae Therapeutics worth?
- Luxvitae Therapeutics's last known valuation is $41.9M.
- How much has Luxvitae Therapeutics raised?
- Luxvitae Therapeutics has raised $14.0M in total funding across 1 recorded rounds.
- When did Luxvitae Therapeutics last raise?
- Luxvitae Therapeutics last raised in Nov 2024 (Early Stage VC), raising $8.5M.